idiopathic noninfectious pneumonia; (3) pulmonary edema (hydrostatic or noncardiogenic); (4) respiratory failure (pulmonary and extrapulmonary etiologies); (5) inflammaFiberoptic bronchoscopy (FOB) has been reported to have a high diagnostic yield and to be safe in BMT tory conditions (diffuse alveolar damage (DAD), bronchiolitis obliterans organizing pneumonia (BOOP), bronchiolitis patients with pulmonary infiltrates. At our institution, BMT patients with respiratory symptoms and/or pulobliterans (BO), and pulmonary graft-versus-host disease); (6) pulmonary hemorrhage; and (7) four percent of FOBs (11 diagnostic FOBs, six nondiagnostic FOBs) changed therapy. Ten complications The use of FOB to evaluate pulmonary infiltrates in BMT patients was not previously standardized at our institution. (15%) occurred in 10 FOBs (five acute respiratory failure, three pneumothoraces, one nose bleed, one death).
and/or antifungal therapy. This approach was approved by
Chest CT criteria the JHOC BMT Clinical Studies Committee and the JHOC Diffuse pulmonary infiltrates were defined as bilateral Pulmonary and Critical Care Medicine Committee. Data infiltrates that involved у1 lobe. Presumed basilar atelectawere collected on all BMT patients who had FOB between sis with bilateral pleural effusion were coded as diffuse 17 March 1993 and 31 August 1995 for respiratory sympinfiltrates. Focal infiltrates were defined as unilateral infiltoms and/or undiagnosed pulmonary infiltrates.
trates involving one lung (uninvolved ipsilateral lobes and contralateral lung appear normal). Pulmonary nodule(s) (Ͻ3 cm in diameter), pulmonary mass (Ͼ3 cm in diameter), Data collection were coded as focal infiltrates.
Existing clinical data were obtained from the Oncology Center Information Systems computer, the Johns Hopkins Patient management Medical Institutions computer, the patient's hospital chart A change in patient management was defined as the withand FOB reports. The following data were collected for drawal or addition of a pharmacologic treatment within 72 each patient within 48 h of FOB: age, gender, underlying h of the procedure for nondiagnostic FOB and within 48 h diagnosis, type and date of BMT, type of infiltrate on chest of the result for a diagnostic FOB. CT (diffuse vs focal), FOB procedure(s) performed (bronchoalveolar lavage (BAL), and transbronchial biopsy (TBBx) vs BAL alone), FOB results (microbiology, cytoBronchoscopy technique pathology, histology), FOB complications (pneumothorax, acute respiratory failure requiring mechanical ventilation FOB was performed by a Pulmonary and Critical Care Medicine fellow and attending physician. The patient or within 24 h of FOB, estimated blood loss Ͼ30 ml, death within 24 h of FOB), platelet number and white blood cell surrogate signed informed consent prior to the procedure which was performed in either a dedicated Endoscopy Unit count, and whether the patient had a platelet transfusion prior to FOB. We also recorded change in pharmacologic (spontaneously breathing patient) or in the patient's room (mechanically ventilated patient). Patients were monitored treatment, date of discharge or death, vital status 6 months after FOB, and results of autopsy or post mortem lung with continuous electrocardiograms and pulse oximetry. Blood pressure was monitored every 5-10 min. The stanbiopsy performed within 10 days of FOB. dard practice for sedation was i.v. midazolam (typical dose 5 mg) and i.v. fentanyl (typical dose 100 g). The nasal passage, vocal cords and airways were anesthetized with Diagnostic criteria lidocaine. If the patient's heart rate was Ͻ100 b.p.m., i.v. atropine (0.5-1 mg) was administered. FOB in mechanIdentification of Pneumocystis carinii or Legionella species from FOB specimens was assumed to be diagnostic of parically ventilated patients was performed via a swivel-Y adaptor while the patient was ventilated with 100% oxygen. enchymal lung infection. Bacterial pneumonia was diagnosed in patients on antibiotics when thoracic CT showed Mechanically ventilated patients were sedated as outlined above and commonly received short-acting neuromuscular an alveolar infiltrate and: (a) blood or pleural fluid cultures grew pathogenic bacteria; or (b) histologic evidence of blocking agents. The bronchoscopist determined which lung segment(s) were lavaged and/or biopsied. In general, acute bacteria pneumonia was demonstrated by surgical lung biopsy or autopsy; or (c) quantitative bacterial cultures the middle lobe or lingula was lavaged and/or biopsied for diffuse infiltrates, and the subsegment most affected on CT from BAL fluid grew Ͼ10 5 colony-forming units. In patients not on antibiotics, in addition to the above, a comwas lavaged and/or biopsied for focal infiltrates. BAL was done using 20 ml or 50 ml aliquots of room temperature patible Gram stain (organisms and neutrophils) and heavy growth was adequate for diagnosing bacterial pneumonia. normal saline. A total of 80 to 150 ml of saline (typical amount 100 ml) was instilled. Contraindications to FOB Cytomegalovirus (CMV) pneumonia was diagnosed by a positive CMV culture (standard viral culture, or early antior BAL were: uncooperative patient, active bronchospasm, hemodynamic instability, unstable arrhythmia, and refracgen culture) and/or characteristic 'owl-eyed' intranuclear and/or intracytoplasmic inclusions on BAL cytopathology tory hypoxemia (P a O 2 Ͻ100 mmHg on high flow oxygen via non-rebreather face mask). TBBx were performed with or TBBx histology. Invasive pulmonary aspergillosis (IPA) was diagnosed in neutropenic patients with compatible fluoroscopy using 2 ml elipcoid cupped forceps. The number of TBBx attempted was determined by the operator infiltrates/nodules on CT by microscopic identification of septate hyphal forms consistent with Aspergillus (BAL (generally [3] [4] [5] [6] . In addition to the general contraindications to FOB, contraindications to TBBx were: (1) 1 h post-platecytopathology or potassium hydroxide (KOH), and/or lung histology) or positive BAL cultures. In non-neutropenic let transfusion platelet number Ͻ30 × 10 9 /l; (2) PT Ͼ15 s; (3) PTT Ͼ1.3 times control; (4) BUN Ͼ50 mg/dl; (5) patients IPA was diagnosed by demonstration of tissue invasion by fungal forms consistent with Aspergillus. Canspontaneous mucocutaneous bleeding; and (6) mechanical ventilation with positive end expiratory pressure. An antedida pneumonia was diagnosed by a positive BAL culture and histologic evidence of tissue invasion. DAD, BOOP, roposterior chest X-ray was obtained 15-45 min after TBBx to examine for pneumothorax. BAL fluid was sub-BO were diagnosed by standard surgical pathology criteria. TBBx specimens which were 'consistent with' DAD, mitted to cytopathology and microbiology (gram stain and aerobic bacterial culture; Legionella culture and direct flu-BOOP, or BO were recorded as diagnostic. CML = chronic myelogenous leukemia; AML = acute myelogenous leukemia; ALL = acute lymphocytic leukemia; NHL = non-Hodgkin's lymphoma; M = male; F = female. Survival data are based on episodes of clinical pneumonia (n = 60). a Others were: aplastic anemia (1), multiple myeloma (3), choriocarcinoma (1), germ cell (1).
orescent antibody, mycology culture and KOH preparation, 2, IPA 3, Candida 2, bacterial pneumonia 2, Legionella pneumonia 1, DAD 2, BOOP 1, and BO 1). One of the mycobacteriology fluorochrome stain and culture, and viral cultures for CMV including early antigen culture, herpes diagnostic FOBs yielded two diagnoses (CMV and bacterial pneumonia) and one yielded three diagnoses (CMV, simplex virus, respiratory syncytial virus, influenza virus, parainfluenza virus, and adenovirus). TBBx specimens Legionella, IPA). One patient had FOB twice for the same episode of CMV pneumonia. Nineteen pulmonary infecwere placed in 10% formaldehyde and submitted for histology, acid fast stains and methenamine silver stains.
tions were identified in 17 FOBs in 13 patients. The diagnostic yield of FOB for focal vs diffuse infiltrates was 24 vs 34%, respectively (P = 0.40). Four noninfectious diagStatistical analysis noses were established with four FOBs in four patients. Forty-seven FOBs in 33 patients were nondiagnostic. SevAll statistics (mean, 2 , Kaplan-Meier survival analysis) were calculated using the SPSS statistical package (version enteen (24%) FOBs (11 diagnostic FOBs and six nondiagnostic FOBs) in 14 patients (15 episodes of pneumonia) 6.1).
2 test was used to compare variables. P р 0.05 was considered statistically significant. When a patient had Ͼ1 changed therapy. Therapy was not changed in either of the two FOBs that yielded Ͼ1 diagnosis. FOB, Kaplan-Meier analysis was done using data from the first FOB.
Of the 68 FOBs, 65 (96%) were done when the patient was receiving antibiotics, 40 (59%) when the patient was on amphotericin, 19 (28%) when the patient was on ganciclovir or fosconnate, 32 (47%) when the patient was on Results antibiotics and amphotericin (18 without acyclovir, 14 with acyclovir), and six (9%) when the patient was on antiBetween 17 March 1993 and 31 August 1995, 391 patients had BMT (123 allogeneic, 268 autologous). During this biotics, amphotericin and ganciclovir or fosconnate. Four patients had surgical lung biopsies done following a period, 52 patients (39 allogeneic and 13 autologous; 32% of allogeneic BMTs, 5% of autologous BMTs, P Ͻ 0.0001) nondiagnostic FOB (two BAL and TBBx, two BAL alone). Three of the surgical biopsies yielded a definitive diagnosis underwent 68 FOBs (42 BAL and TBBx, 26 BAL alone) for 60 episodes of clinical pneumonia (fever, respiratory (two BOOP, one pulmonary VOD) and two changed treatsymptoms and/or pulmonary infiltrates). Ten patients had two FOBs, three patients had three FOBs, and eight patients associated with the diagnostic yield, change in treatment, Dx = diagnostic; Rx = treatment; NS = not significant.
or patient survival ( Table 2 ).
The number of days status post-BMT when FOB was done was not sig- Table 3 reports the results (diagnosis, change in treat- FOBs in 19 patients) yielded a diagnosis (CMV 10, PCP ment (BOOP, and pulmonary VOD). Seven patients had examination of post mortem lung tissue within 10 days of FOB (five autopsies, two lung biopsies) of which one yielded a diagnosis not found on the prior FOB (CMV pneumonia). Hospital and 6-month survival for the 60 episodes of clinical pneumonia was 47 and 32%, respectively (Table  1) . Survival by Kaplan-Meier analysis demonstrated that patients who had a diagnostic FOB or a FOB that changed therapy did not have an increased probability of survival compared to patients who had a FOB that did not yield a diagnosis or change therapy (Figures 1 and 2 ). 
Complications
Ten complications (15%) occurred in 10 FOBs involving nine patients. Five patients (7%) required mechanical ventilation for acute respiratory failure within 24 h of FOB. Three pneumothoraces (4%) occurred (two after BAL in mechanically ventilated patients, one after TBBx and BAL in a spontaneously breathing patient) but none required a chest tube and all resolved with conservative management. There was one bleeding complication (1.5%): a nose bleed parenchymal hemorrhage following TBBx or BAL. One patient (1.5%) died within 24 h of FOB. An autopsy indiof pneumonia with non-lobar pulmonary infiltrates without evidence of lower respiratory infection defined as a lack of cated the cause of death was sepsis and there was no indication that the patient's death was related to the procedure. improvement on broad spectrum antibiotics and/or a nondiagnostic FOB. 16 The historical incidence of idiopathic interOverall, two of the nine patients (22%) who had FOBrelated complications (pneumothorax, mechanical ventstitial pneumonitis (defined as PO 2 on room air Ͻ70 mmHg, nonlobar pulmonary infiltrates in the absence of ilation) were discharged alive from the hospital. This was not statistically different from hospital survival in patients heart failure and no evidence of infection based on culture and histology of lung tissue) at our BMT center was 19% without FOB-related complications (51%; P = 0.30).
and 7% for allogeneic and autologous BMT patients, respectively. 17 The incidence of IPS at other BMT centers is similar (10-20%) . 16 The reduction in the number of cases Discussion of CMV pneumonia relative to idiopathic interstitial pneumonitis responsible for diffuse infiltrates at our BMT center In our BMT patient population, FOB had a low diagnostic yield (31%), infrequently changed therapy (24%), and a could partly account for the low FOB diagnostic yield seen in this series, given that IPS cannot be definitively diagsignificant complication rate (15%). Hospital and 6-month survival in patients who had a diagnostic FOB or a FOB nosed by FOB. In our series, FOB diagnosed nine of 10 patients with that changed treatment was not different compared to patients who had a nondiagnostic FOB or a FOB which did clinically recognized CMV pneumonia. This is similar to other reports in BMT patients. 7, 8 The single case of CMV not change therapy.
This observation raises an important issue. What is the pneumonia not identified by FOB in this report was diagnosed at autopsy 10 days after FOB in a patient with role of FOB in evaluating BMT patients with pulmonary infiltrates and respiratory symptoms? A diagnostic prochronic graft-versus-host disease, CMV colitis, CMV viremia, acute respiratory distress syndrome and multicedure may benefit a patient by: (1) providing a diagnosis; (2) guiding treatment; (3) predicting prognosis. In this organ system failure. Post-mortem lung pathology showed 'extensive acute organizing diffuse alveolar damage' and report, FOB was found wanting on all three accounts. This raises the question whether the risk of FOB justifies the 'rare CMV positive cells'. Our experience with CMV pneumonia strongly suggests that the low overall diagnostic benefit and should FOB be done routinely to evaluate pulmonary infiltrates in BMT patients. A definitive statement yield of FOB was not an artifact of a technical problem in obtaining, transporting, processing or culturing specimens. would require this observation be confirmed in a large controlled clinical trial comparing survival in BMT patients
The yield of FOB in our series was not spuriously depressed by overly stringent diagnostic criteria. The diagwith clinical pneumonia randomized to empiric antimicrobial therapy with or without FOB and antimicrobial therapy nostic criteria were similar to those used by others. 6, 7, 12 The diagnosis of BOOP, BO, and DAD by TBBx were included dictated by FOB and/or other invasive diagnostic procedures. Enthusiasm for such a clinical trial is problematic.
which, given the size of the biopsies, may not be representative of the actual lung pathology. 18 The diagnostic yield Multiple uncontrolled reports have failed to show improved survival in immunocompromised patients who had open for FOB would be 25% if these noninfectious TBBx diagnoses are excluded. If the diagnostic criteria were too rigorlung biopsies, 14 and FOB has a high diagnostic yield for CMV pneumonia, a common cause of diffuse pulmonary ous, but the information obtained from FOB was used to direct patient management, or improved patient outcome, infiltrates in BMT patients. 7, 8 The medical literature for FOB in BMT patients is sumthis would be reflected in the change in therapy (Tables 2  and 3 ) and survival data (Figures 1 and 2 ). This was not marized in Table 4 . FOB has been reported to yield a specific diagnosis in 42% (13) to 89% (8) of patients. The the case. The addition of TBBx was of limited benefit. TBBx with yield in our series (31%) was less than expected based on the medical literature. The explanation for this was not aggressive platelet support was safe (no cases of pneumothorax requiring a chest tube or significant parenchymal obvious. Patient population, treatment protocols, and patient selection criteria vary between institutions and may bleeding in 42 FOBs). But, TBBx provided only one additional infectious diagnoses (Candida pneumonia) and influence the diagnostic yield of FOB and patient survival. Our patient population was heterogenous, was identified never by itself changed therapy. These results support the contention that the routine use of TBBx in this setting canprospectively, and all FOBs were clinically indicated. The spectrum and timing of diagnosis in our series were similar not be recommended. 2, 8 In this series, all patients had CT scans within 48 h of to previous reports, [1] [2] [3] suggesting that the low diagnostic yield was not an artifact of the patient population or selec-FOB. CT scans are more sensitive than plain chest X-rays in detecting lung nodules and metastasis, 19 and may be tion criteria.
In allogeneic BMT patients, CMV pneumonia is the most more sensitive than chest X-rays in detecting early invasive pulmonary aspergillosis and other opportunistic pulmonary common pulmonary infection between 30-180 days after marrow transplant. [1] [2] [3] Historically, the incidence of CMV infections in BMT patients. 19, 20 Fewer pathogenic organisms may be present in the lung when CT demonstrates pneumonia at our institution has been low (allogeneic, 12%; autologous, 2%). 15 Other BMT centers have reported an pulmonary infiltrates not seen on chest X-ray. This may translate into a lower recovery rate by FOB. incidence as high as 25% for allogeneic BMT patients. 2, 3 Idiopathic pneumonia syndrome (IPS) in BMT patients is BMT patients with infiltrates are commonly on multiple broad spectrum antibiotics with or without antifungal a clinical syndrome characterized by signs and symptoms 686 these empiric therapies may decrease the FOB yield for infectious pneumonias. Prior antibiotic therapy in immunoIn our series, respiratory failure requiring mechanical ventilation was the most common adverse event due to competent patients with ventilator-associated pneumonia drastically reduces the sensitivity and specificity of bron-FOB (7%) and is similar to a report in 71 BMT patients (4%; P = 0.46). 12 The five patients who required mechanchoscopically obtained quantitative bacterial cultures. 21, 22 In this series, 94% of FOBs were done when the patient was ical ventilation for respiratory failure after FOB had diffuse infiltrates, and high oxygen requirements (50-100% O 2 via receiving empiric antimicrobial therapy. One other study of FOB in BMT patients has reported the prevalence of face mask) prior to FOB. Which patients would have required mechanical ventilation had they not had FOB is empiric therapy (94%).
12 Prophylactic or pre-emptive antimicrobial therapy is common in BMT patients because prenot known. The temporal relationship between FOB and mechanical ventilation speaks for itself, and the grim progventing infections or treating asymptomatic infections rather than treating established infections is associated with nosis (approximately 95% hospital mortality) of BMT patients who require mechanical ventilation is well docubetter patient survival. 23 The complication rate for FOB in this series was 15% mented. 2, 3 Hospital survival for our BMT patients who were mechanically ventilated at FOB or within 24 h of FOB emphasizing that FOB is not a benign undertaking in BMT patients. Although six of the FOB complications (five was 15%. In BMT patients, two studies have reported the impact mechanical ventilation and one death) may not have been a direct consequence of the procedure, the adverse event of FOB on therapy. 8 Campbell et al 10 reported that 63% of FOBs were used to modify therapy and Dunagan et al 12 rate directly attributable to FOB would be 6%. FOB complications in BMT patients has been reported to vary reported that 42% of FOBs altered antimicrobial treatment.
In this report only a quarter of FOBs changed therapy and, between 0% and 40% (Refs 6, 8 and 9; Table 4 ). The explanation for the wide range of complication rates in the literaas in the above referenced studies, this did not translate into improved survival. Patient survival, in addition to being ture is not certain. The study methods of prior reports (retrospective, based on FOB reports or bronchoscopist's easier to define than diagnostic FOB or change in treatment, is the most important outcome. recall, lack of defined outcomes, no comment regarding data verification) suggest serious limitations and a likeliBased on this series, the value of routine diagnostic FOB in BMT patients with clinical pneumonia should be rehood of under reporting and/or a tendency to report only serious or obvious complications. For example, two large evaluated. The diagnostic yield was low, the results infrequently change treatment and the knowledge gained by series of FOB complications in general medical patients report no cases of arrhythmias in 69 000 FOBs, 24 
